Details of the Drug

General Information of Drug (ID: DMZMG96)

• Drug Name: ALLN-346

Indication

Disease Entry	ICD 11	Status	REF
Chronic kidney disease	GB61	Phase 2	[1]
Gout	FA25	Phase 2	[2]

• Drug Type: Enzyme replacement
• Cross-matching ID: TTD ID: DG31WX
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04987294) A Randomized, Double-Blind, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects With Gout and Mild to Moderate Chronic Kidney Disease. U.S.National Institutes of Health.
• [2] ClinicalTrials.gov (NCT04987242) An Inpatient, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects. U.S.National Institutes of Health.